PLYMOUTH, Minn., July 24 /PRNewswire-FirstCall/ -- ev3 Inc. (Nasdaq: EVVV) today announced a revised date to report its 2008 second quarter and year-to-date financial results. ev3 will now report its 2008 second quarter and year-to-date financial results on Monday, July 28, 2008, after regular market trading hours.
The company will host a conference call and webcast at 7:30 a.m. Central Time (8:30 a.m. Eastern Time) on Tuesday, July 29, 2008. ev3 management will review its second quarter operating results and future outlook, followed by a question and answer session.
The conference call will be available to interested parties through a live audio webcast at http://ir.ev3.net, where it will be archived and accessible for approximately 90 days. The live dial-in number for the call is 888-679-8033 (U.S.) or 617-213-4846 (International). The participant passcode is 64950600.
If you do not have access to the Internet and want to listen to an audio replay of the conference call, dial 888-286-8010 (U.S.) or 617-801-6888 (International) and enter passcode 10431647. The audio replay will be available beginning at 9:30 a.m. Central Time on Tuesday, July 29, 2008 until Tuesday, August 5, 2008.
About ev3 Inc.
Since its founding in 2000, ev3 has been dedicated to developing
innovative, breakthrough and clinically proven technologies and solutions
for the treatment of lower extremity vascular and neurovascular diseases.
ev3's products are used by endovascular specialists to treat a wide range
of peripheral vascular and neurovascular diseases and disorders. The
company offers a comprehensive portfolio of treatment options, including
the primary interventional technologies used today -- peripheral
angioplasty balloons, stents, plaque excision systems, embolic protection
devices, liquid embolics, embolization coils, thrombectomy catheters and
occlusion balloons. More information about the company
|SOURCE ev3 Inc.|
Copyright©2008 PR Newswire.
All rights reserved